KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artisan Partners Asset Management (APAM) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Artisan Partners Asset Management (APAM) over the last 14 years, with Q3 2025 value amounting to $300.2 million.

  • Artisan Partners Asset Management's Cash & Equivalents rose 1819.62% to $300.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $300.2 million, marking a year-over-year increase of 1819.62%. This contributed to the annual value of $201.2 million for FY2024, which is 4266.71% up from last year.
  • Per Artisan Partners Asset Management's latest filing, its Cash & Equivalents stood at $300.2 million for Q3 2025, which was up 1819.62% from $244.9 million recorded in Q2 2025.
  • In the past 5 years, Artisan Partners Asset Management's Cash & Equivalents ranged from a high of $300.2 million in Q3 2025 and a low of $114.8 million during Q4 2022
  • Moreover, its 5-year median value for Cash & Equivalents was $195.4 million (2024), whereas its average is $198.7 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 3931.49% in 2022, then surged by 4266.71% in 2024.
  • Quarter analysis of 5 years shows Artisan Partners Asset Management's Cash & Equivalents stood at $189.2 million in 2021, then crashed by 39.31% to $114.8 million in 2022, then increased by 22.8% to $141.0 million in 2023, then soared by 42.67% to $201.2 million in 2024, then surged by 49.2% to $300.2 million in 2025.
  • Its Cash & Equivalents stands at $300.2 million for Q3 2025, versus $244.9 million for Q2 2025 and $212.9 million for Q1 2025.